Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Jevtana

J&J drug offers hope in advanced prostate cancer

Men with advanced prostate cancer lived nearly four months longer on a new pill from Johnson & Johnson, according to keenly awaited study data that researchers said would change clinical practice.

Abiraterone, which could reach the market next year, provides a new option for men with an aggressive type of prostate cancer.

Its… J&J drug offers hope in advanced prostate cancer   



urease inhibitor1 - gamete intrafallopian transfer1 - hemorrhagic inflammation1 - overactive bladder syndrome1 - national institutes of health2 - gastrointestinal absorption inhibitor1 - preterm births1 - genital tracts1 - tissue matching1 - physicians1 - pkd2 - metanephros1 - conventional ultrasound1 - mitotane1 - mri scan1 - aggressive treatment1 - gonococcal infections1 - rituximab1 - fallopian tubes1 - crescenteric glomerulonephritis1 - mental health1 - fox chase cancer center2 - prostate adenocarcinoma1 - hyperglycemia1 - prostate treatment system1 - rokitansky syndrome1 - glans1 - matrix component3 - intermittent urinary stream1 - chronic dialysis1 -